Correlation Between Medeon Biodesign and SciVision Biotech
Can any of the company-specific risk be diversified away by investing in both Medeon Biodesign and SciVision Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medeon Biodesign and SciVision Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medeon Biodesign and SciVision Biotech, you can compare the effects of market volatilities on Medeon Biodesign and SciVision Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medeon Biodesign with a short position of SciVision Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medeon Biodesign and SciVision Biotech.
Diversification Opportunities for Medeon Biodesign and SciVision Biotech
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Medeon and SciVision is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Medeon Biodesign and SciVision Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SciVision Biotech and Medeon Biodesign is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medeon Biodesign are associated (or correlated) with SciVision Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SciVision Biotech has no effect on the direction of Medeon Biodesign i.e., Medeon Biodesign and SciVision Biotech go up and down completely randomly.
Pair Corralation between Medeon Biodesign and SciVision Biotech
Assuming the 90 days trading horizon Medeon Biodesign is expected to under-perform the SciVision Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Medeon Biodesign is 2.38 times less risky than SciVision Biotech. The stock trades about -0.49 of its potential returns per unit of risk. The SciVision Biotech is currently generating about -0.19 of returns per unit of risk over similar time horizon. If you would invest 10,250 in SciVision Biotech on August 30, 2024 and sell it today you would lose (1,050) from holding SciVision Biotech or give up 10.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Medeon Biodesign vs. SciVision Biotech
Performance |
| Timeline |
| Medeon Biodesign |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| SciVision Biotech |
Medeon Biodesign and SciVision Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Medeon Biodesign and SciVision Biotech
The main advantage of trading using opposite Medeon Biodesign and SciVision Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medeon Biodesign position performs unexpectedly, SciVision Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SciVision Biotech will offset losses from the drop in SciVision Biotech's long position.| Medeon Biodesign vs. Hotel Holiday Garden | Medeon Biodesign vs. First Hotel Co | Medeon Biodesign vs. Chernan Metal Industrial | Medeon Biodesign vs. Chinese Maritime Transport |
| SciVision Biotech vs. Maxigen Biotech | SciVision Biotech vs. Chunghwa Chemical Synthesis | SciVision Biotech vs. Sinphar Pharmaceutical Co | SciVision Biotech vs. ScinoPharm Taiwan |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |